De novo diabetes mellitus in kidney allografts: nodular sclerosis and diffuse glomerulosclerosis leading to graft failure.

Key words: de novo diabetic diffuse glomerulosclerosis; The patient's graft functioned well (mean serum creatinine of 124 mmol/l) and her fasting glucose was de novo diabetic nodular glomerulosclerosis; post-transplant diabetes mellitus; renal transplant normal (range 3.8–5.2 mmol/l) during the first 7 months after surgery. Immunosuppression consisted of cyclosporin 12 mg/kg/day and subsequently the dose was adjusted aiming at a whole-blood trough level of